000 | 01980 a2200529 4500 | ||
---|---|---|---|
005 | 20250516124639.0 | ||
264 | 0 | _c20130827 | |
008 | 201308s 0 0 eng d | ||
022 | _a2567-689X | ||
024 | 7 |
_a10.1160/TH12-05-0326 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMassaro, Marika | |
245 | 0 | 0 |
_aDipyridamole decreases inflammatory metalloproteinase-9 expression and release by human monocytes. _h[electronic resource] |
260 |
_bThrombosis and haemostasis _cFeb 2013 |
||
300 |
_a280-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAnti-Inflammatory Agents _xpharmacology |
650 | 0 | 4 |
_aCyclic AMP _xmetabolism |
650 | 0 | 4 |
_aCyclic GMP _xmetabolism |
650 | 0 | 4 |
_aDipyridamole _xpharmacology |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDown-Regulation |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aI-kappa B Proteins _xmetabolism |
650 | 0 | 4 |
_aInflammation Mediators _xmetabolism |
650 | 0 | 4 |
_aMatrix Metalloproteinase 9 _xgenetics |
650 | 0 | 4 |
_aMonocytes _xdrug effects |
650 | 0 | 4 | _aNF-KappaB Inhibitor alpha |
650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aTissue Inhibitor of Metalloproteinase-1 _xmetabolism |
650 | 0 | 4 |
_aTranscription Factor AP-1 _xmetabolism |
650 | 0 | 4 |
_aTranscription Factor RelA _xmetabolism |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xmetabolism |
650 | 0 | 4 | _aU937 Cells |
650 | 0 | 4 |
_ap38 Mitogen-Activated Protein Kinases _xmetabolism |
700 | 1 | _aScoditti, Egeria | |
700 | 1 | _aCarluccio, Maria Annunziata | |
700 | 1 | _aPellegrino, Mariangela | |
700 | 1 | _aCalabriso, Nadia | |
700 | 1 | _aStorelli, Carlo | |
700 | 1 | _aMartines, Giuseppe | |
700 | 1 | _aDe Caterina, Raffaele | |
773 | 0 |
_tThrombosis and haemostasis _gvol. 109 _gno. 2 _gp. 280-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1160/TH12-05-0326 _zAvailable from publisher's website |
999 |
_c22344755 _d22344755 |